the whole psychedelic treatment space will see large gains across 2024/25 imo as the treatments move to the clinical setting
https://www.filament.health/news/filament-health-completes-the-first-export-of-botanical-psilocybin-to-australia The shipment is believed to be the first botanical psilocybin to be exported to Australia and was received by Reset Mind Sciences Ltd. (“Reset”), a psychedelic-focused subsidiary of Little Green Pharma, a biotechnology company dedicated to developing natural quality medicines to help those living with chronic conditions. Reset will use Filament’s drug product for research purposes.
holders here are perfectly placed both in company development and market position - yep....JL and the BOD to blame of course
IHL Price at posting:
4.1¢ Sentiment: None Disclosure: Held
